Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China.
Department of Radiology, the Second Xiangya Hospital, Central South University, Changsha 410011, China; Department of Diagnostic Radiology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Biochim Biophys Acta Mol Basis Dis. 2024 Dec;1870(8):167493. doi: 10.1016/j.bbadis.2024.167493. Epub 2024 Sep 2.
The immune landscape of distant unablated tumors following insufficient microwave ablation (iMWA) in hepatocellular carcinoma (HCC) remains to be clarified. The objective of this study is to define the abscopal immune landscape in distant unablated tumor before and after iMWA for HCC. Two treatment-naive patients were recruited for tumor tissue sampling, of each with two HCC lesions. Tumor samples were obtained at before and after microwave ablation in distant unablated sites for single-cell RNA sequencing (scRNA-seq). Mouse model with bilateral hepatoma tumors were developed, and distant unablated tumors were analyzed using multicolor immunofluorescence, RNA sequencing and flow cytometry. The scRNA-seq revealed that a reduced proportion of CD8 T cells and an increased proportion of myeloid-derived suppressor cells (MDSCs) were observed in the distant unablated tumor microenvironment (TME). A notable disruption was observed in the lipid metabolism of tumor-associated immune cells, accompanied by an upregulated expression of CD36 in tumor-infiltrating immune cells in distant unablated tumor. The administration of a CD36 inhibitor has been demonstrated to ameliorate the adverse effects induced by iMWA, primarily by reinstating the anti-tumor responses of T cells in distant unablated tumor. These findings explain the recurrence and progression of tumors after iMWA and provide a new target of immunotherapy for HCC.
在肝细胞癌 (HCC) 中,微波消融 (MWA) 不充分后远处未消融肿瘤的免疫景观仍不清楚。本研究旨在定义 HCC 患者 iMWA 前后远处未消融肿瘤的免疫全景。招募了两名未经治疗的患者进行肿瘤组织采样,每位患者各有两个 HCC 病变。在 MWA 前后对远处未消融部位的肿瘤样本进行单细胞 RNA 测序 (scRNA-seq)。建立了双侧肝癌小鼠模型,并对远处未消融肿瘤进行了多色免疫荧光、RNA 测序和流式细胞术分析。scRNA-seq 显示,远处未消融肿瘤微环境 (TME) 中 CD8 T 细胞比例降低,髓系来源抑制细胞 (MDSCs) 比例增加。肿瘤相关免疫细胞的脂质代谢明显受到干扰,并且在远处未消融肿瘤浸润免疫细胞中 CD36 的表达上调。CD36 抑制剂的给药已被证明可以改善 iMWA 引起的不良反应,主要是通过恢复远处未消融肿瘤中 T 细胞的抗肿瘤反应。这些发现解释了 iMWA 后肿瘤的复发和进展,并为 HCC 的免疫治疗提供了新的靶点。